A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants
Manu Sharma(Hertie Institute for Clinical Brain Research), Eng King Tan(Singapore General Hospital), Lars Bertram(Universitat Internacional de Catalunya), Jessie Theuns(University of Antwerp), Carl E Clarke(German Center for Neurodegenerative Diseases), Suzana Gispert(Goethe University Frankfurt), Georgios M. Hadjigeorgiou(University of Bonn), George D. Mellick(Griffith University), Gaëtan Garraux(German Center for Neurodegenerative Diseases), Ekaterina Rogaeva(University of Toronto), Nobutaka Hattori(Juntendo University Hospital), Maria Bozi(German Center for Neurodegenerative Diseases), Aldo Quattrone(Magna Graecia University), Grazia Annesi(German Center for Neurodegenerative Diseases), Barbara Jasińska‐Myga(Medical University of Silesia), Thomas Meitnger(Helmholtz Zentrum München), Juei‐Jueng Lin(Chung Shan Medical University Hospital), Vincent Mok(Chinese University of Hong Kong), David Crosiers(University of Antwerp), Alexis Brice(Inserm), Alexander Zimprich(Ludwig-Maximilians-Universität München), Jan Aasly(Norwegian University of Science and Technology), Joanne Stockton(German Center for Neurodegenerative Diseases), Andrew A. Hicks(Amsterdam Neuroscience), Matthew J. Farrer(University of Florida), Irene Pichler(Amsterdam Neuroscience), Wataru Satake(German Center for Neurodegenerative Diseases), Peter Lichtner(The University of Melbourne), Maurizio Facheris(German Center for Neurodegenerative Diseases), Georg Auburger(Goethe University Frankfurt), Maria Barcikowska(Polish Academy of Sciences), Peter P. Pramstaller(Eurac Research), John P. A. Ioannidis(Innovative Research (United States)), Suzanne Lesage(Centre National de la Recherche Scientifique), Owen A. Ross(Jacksonville College), Cécile Libioulle(Centre Hospitalier Universitaire de Liège), Zygmunt Jamrozik(Medical University of Warsaw), Sung Sup Park(German Center for Neurodegenerative Diseases), Karen Morrison(University Hospitals Birmingham NHS Foundation Trust), Leonidas Stefanis(National and Kapodistrian University of Athens), Carles Vilariño‐Güell(German Center for Neurodegenerative Diseases), Beom S. Jeon(German Center for Neurodegenerative Diseases), Anna Krygowska‐Wajs(Jagiellonian University), Peter A. Silburn(Griffith University), Grzegorz Opala(Medical University of Silesia), Miho Murata(The University of Osaka), Tim M. Strom(Ludwig-Maximilians-Universität München), Anthony E. Lang(University of Toronto), Timothy Lynch(University College Dublin), Christina M. Lill(University of Münster)
Cited by 107
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k